oasis 4 trial semaglutide 🚨 Oral 25 mg delivers double-digit weight loss in OASIS-4 (Phase 3 trial) - 🥼🧪Slide Deck: Efficacy and safety

Some of the potential benefits of these GLP-1 medications include: Weight loss Decrease in food noise Reduction in appetite Decrease in stomach emptying so you will feel fuller longer after eating a meal Stimulation of the pancreas to release insulin Lower blood sugar levels Lower blood pressure Improved lipid disorders Improved fatty liver Reduction in the risk of heart and kidney disease Candidates If you suffer from obesity or at least one weight-related condition, you may be a great candidate for semaglutide or tirzepatide

Scott Nass, Dr

It might work for some, but for me, it hasnt lived up to its promises

From a broader immunologic perspective, Karacabeyli and Lacaille 1 note that GLP-1 RAs may influence shared inflammatory pathways involved in immune-mediated inflammatory diseases (IMIDs), including psoriasis and inflammatory arthritis

Semaglutide is designed to be increased gradually